Actuate Therapeutics’ $22,4 Million Initial Public Offering

BakerHostetler provided legal counsel to Actuate in its IPO, while McGuireWoods represented the underwriters.Actuate Therapeutics, Inc. (Nasdaq: ACTU) announced the closing of its initial public offering…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here